Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity
- 23 August 2008
- Vol. 44 (1) , 141-148
- https://doi.org/10.1016/j.cyto.2008.07.004
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- The Antiinflammatory Cytokine Interleukin-1 Receptor Antagonist Protects from High-Fat Diet-Induced HyperglycemiaEndocrinology, 2008
- New agents in development for the management of obesityInternational Journal Of Clinical Practice, 2007
- Interleukin-1β-Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 ExpressionEndocrinology, 2007
- Twenty years of research on cytokine-induced sickness behaviorBrain, Behavior, and Immunity, 2006
- IL-1 resets glucose homeostasis at central levelsProceedings of the National Academy of Sciences, 2006
- Endocrine and signalling role of adipose tissue: new perspectives on fatActa Physiologica Scandinavica, 2005
- Interleukin-1β-induced Rat Pancreatic Islet Nitric Oxide Synthesis Requires Both the p38 and Extracellular Signal-regulated Kinase 1/2 Mitogen-activated Protein KinasesJournal of Biological Chemistry, 1998
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.Journal of Clinical Investigation, 1995
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993
- Neuroendocrine, Sympathetic and Metabolic Responses Induced by Interleukin-1Neuroendocrinology, 1989